a54038.htm - Generated by SEC Publisher for SEC Filing

Filed pursuant to Rule 433
Registration Statement No. 333-180300-03
FINANCIAL PRODUCTS
FACT SHEET (T220)

Offering Period: June 6, 2013 – June 20, 2013
6 Year Accelerated Barrier Notes Linked to the EURO STOXX 50^® Index

Return Profile

•

6-year Accelerated Barrier Notes linked to the performance of the EURO STOXX 50^®Index.

•

If the Final Level is equal to or greater than the Initial Level, the investor will be entitled to receive leveraged participation in the appreciation of the Underlying.

•

If the Final Level is less than the Initial Level and a Knock-In Event does not occur, the investor is entitled to receive the principal amount at maturity.

•

If the Final Level is less than the Initial Level and a Knock-In Event occurs, the investor will be entitled to receive a payment at maturity that will be less than the principal amount.

•

Any payment on the securities is subject to our ability to pay our obligations as they become due.

Terms & Knock-In Event

Issuer:	Credit Suisse AG (“Credit Suisse”), Nassau Branch
Trade Date:	Expected to be June 21, 2013
Settlement Date:	Expected to be June 28, 2013
Underlying:	The EURO STOXX 50^® Index
Upside Participation Rate:	Expected to be between [165.00-175.00]% (to be determined on the Trade Date).
Redemption Amount:	An amount in cash equal to the principal amount of the securities held multiplied by the sum of 1 plus the Underlying Return.
Underlying Return:	If (a) the Final Level is equal to or greater than the Initial Level, then: Upside Participation Rate * [(Final Level – Initial Level)/Initial Level]; or (b) the Final Level is less than the Initial Level and (i) a Knock-In Event occurs, then: [(Final Level – Initial Level)/Initial Level]; or (ii) a Knock-In Event does not occur, then: zero.
Knock-In Level:	Approximately 50% of the Initial Level (to be determined on the Trade Date).
Knock-In Event:	A Knock-In Event occurs if the Final Level of the Underlying is equal to or less than the Knock-In Level.
Initial Level:	The closing level of the Underlying on the Trade Date.
Final Level:	The closing level of the Underlying on the Valuation Date.
Valuation Date:	June 21, 2019
Maturity Date:	June 28, 2019
CUSIP:	22547Q3R5

Benefits

•

If the Final Level of the Underlying appreciates from the Initial Level, offers uncapped levered participation in the appreciation of the Underlying.

•

Reduced downside risk due to a 50% contingent buffer.

Hypothetical Returns at Maturity

Percentage Change from Initial Level to Final Level	Underlying Return (1)	Redemption Amount per $1,000 Principal Amount (1)(2)
50%	85%	$1,850
40%	68%	$1,680
30%	51%	$1,510
20%	34%	$1,340
10%	17%	$1,170
0%	0%	$1,000
-10%	0%	$1,000
-20%	0%	$1,000
-40%	-0%	$1,000
-50%	-50%	$500
-60%	-60%	$400

(1)

Assumes an Upside Participation Rate of 170% (the midpoint of the expected range) (to be determined on Trade Date).

(2)

The hypothetical Redemption Amounts set forth above are for illustrative purposes only and may not be the actual returns applicable to the investor. The numbers appearing in the table have been rounded for ease of analysis.

Product Risks

•

Investment may result in a loss of up to 100% of principal.

•

The value of the securities and the payment of any amount due on the securities are subject to the credit risk of Credit Suisse.

•

The securities do not pay interest.

•

The return on the securities is affected by the Final Level and the occurrence of a Knock-In Event.

•

Redemption Amount will be less than the principal amount if the Final Level is less than the Initial Level and a Knock-In Event occurs. In such case, the return will be based on the percentage change in the Underlying.

(See “Additional Risk Considerations” on the next page.)

Product Summary

Horizon (years)		6 Year
Principal Repayment		Principal at Risk
Investment Objective		Appreciation
Market Outlook		Bullish

Offering Period: June 6, 2013 – June 20, 2013
6 Year CertPlus Securities Linked to the EuroStoxx 50 Index

The risks set forth in the section entitled “Product Risks” on the preceding page and this section “Additional Risk Considerations” are only intended as summaries of some of the risks relating to an investment in the securities. Prior to investing in the securities, you should, in particular, review the “Product Risks” and “Additional Risk Considerations” sections herein, the “Selected Risk Considerations” section in the pricing supplement, and the “Risk Factors” section of the product supplement, which set forth risks related to an investment in the securities.

IRS Circular 230 Disclosure: Credit Suisse and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used and cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated with Credit Suisse of any of the matters address herein or for the purpose of avoiding U.S. tax-related penalties.

Investment suitability must be determined individually for each investor, and the financial instruments described herein may not be suitable for all investors. The products described herein should generally be held to maturity as early sales could result in lower than anticipated returns. This information is not intended to provide and should not be relied upon as providing accounting, legal, regulatory or tax advice. Investors should consult with their own advisors as to these matters.

This material is not a product of Credit Suisse Research Departments. Financial Products may involve a high degree of risk, and may be appropriate investments only for sophisticated investors who are capable of understanding and assuming the risks involved. Credit Suisse and its affiliates may have positions (long or short), effect transactions or make markets in securities or financial instruments mentioned herein (or options with respect thereto), or provide advice or loans to, or participate in the underwriting or restructuring of the obligations, issuers of the stocks comprising the applicable index, indices or fund mentioned herein. Credit Suisse is a member of FINRA, NYSE and SIPC. Clients should contact their salespersons at, and execute transactions through, a Credit Suisse entity qualified in their home jurisdiction unless governing law permits otherwise.

You may revoke your offer to purchase the securities at any time prior to the time at which we accept such offer on the date the securities are priced. We reserve the right to change the terms of, or reject any offer to purchase the securities prior to their issuance. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.

This document is a summary of the terms of the securities and factors that you should consider before deciding to invest in the securities. Credit Suisse has filed a registration statement (including pricing supplement, product supplement, underlying supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this offering summary relates. Before you invest, you should read this summary together with the Preliminary Pricing Supplement dated June 6, 2013, Underlying Supplement dated November 19, 2012, Product Supplement No. T-I dated March 23, 2012, Prospectus Supplement dated March 23, 2012 and Prospectus dated March 23, 2012 to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the securities. You may get these documents without cost by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, Credit Suisse, any agent or any dealer participating in this offering will arrange to send you the pricing supplement, product supplement, underlying supplement, prospectus supplement and prospectus if you so request by calling toll-free 1 (800) 221-1037.

You may access the product supplement, underlying supplement, prospectus supplement and prospectus on the SEC website at www.sec.gov or by clicking on the hyperlinks to each of the respective documents incorporated by reference in the pricing supplement.